Clinical trial
The Analysis of End-stage Renal Disease for Outcomes in Pancreatic Surgery
NCT07405099 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Analysis of End-stage Renal Disease for Outcomes in Pancreatic Surgery
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2016
- Completion date
- December 31, 2034
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.